1nhaler logo

1nhaler

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$2.5M


1nhaler develops a breath-activated, single-dose, disposable dry powder inhaler made from recyclable materials, aiming to partner with global firms to enhance drug delivery for patients.

Total Funding

$2.5M

Headquarters

Edinburgh, United Kingdom

Founded

N/A

Focus Areas

Drug delivery devices
Breath-activated inhaler
Single-dose
Disposable
Dry powder inhaler
Recyclable cardboard

Investors

British Business Investments logo
Archangels logo